Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers Results available

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

ClinicalTrials.gov ID: NCT00493285

Public ClinicalTrials.gov record NCT00493285. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability,Immunogenicity, and Viral Shedding of MEDI-534, a Live, Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV), in Healthy Children 6 to <24 Months of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The overall objective of the MEDI-534 clinical development program is to evaluate the safety, efficacy and tolerability of MEDI-534 for the prevention of serious RSV and PIV3 disease in young infants.

Study identification

NCT ID
NCT00493285
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
MedImmune LLC
Industry
Enrollment
49 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months to 23 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2007 (Type not available)
Primary completion
Nov 2009 (Actual)
Completion
Apr 2010 (Actual)
Last update posted
Jul 19, 2012

2007 – 2010

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
Arkansas Pediatric Research Division Conway Arkansas 72033 —
Arkansas Pediatric Clinic Little Rock Arkansas 72205 —
THe Children's Hospital Aurora Colorado 80045 —
Miami Children's Hospital Miami Florida 33155 —
Pediatric Partners Palm Beach Gardens Florida 33410 —
North Georgia Clinical Research Center Dalton Georgia 30721 —
University Consultants in Allergy and Immunology Chicago Illinois 60612 —
Children's Memorial Hospital Chicago Illinois 61614 —
University of Maryland, Baltimore Baltimore Maryland 21201 —
Tufts-New England Medical Center Boston Massachusetts 02111 —
Craig A. Spiegel, MD Bridgeton Missouri 63044 —
Meridian Clinical Research, LLC Omaha Nebraska 68134 —
United Medical Associates Binghamton New York 13901 —
Withrop University Hospital Mineola New York 11501 —
SUNY Upstate Medical University Syracuse New York 13210 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
University Hospitals case Medical Center Cleveland Ohio 44106 —
MetroHealth Medical Center Cleveland Ohio 44109 —
St. Vincent Mercy Medical Center Mercy Children's Hospital Toledo Ohio 43608 —
Primary Physicians Research, Inc. Pittsburgh Pennsylvania 15241 —
Sanford Children's Specialty Clinic Sioux Falls South Dakota 57117 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
University of Texas Health Science Center of Houston Medical School Houston Texas 77030 —
Bear Care Pediatrics Ogden Utah 84405 —
Copperview Medical Center South Jordan Utah 84095 —
Virginia Commonwealth University Richmond Virginia 23219 —
Advanced Pediatrics Vienna Virginia 22180 —
Rockwood Clinic Research Center Spokane Washington 99202 —
Marshall University Joan C. Edwards School of Medicine Huntington West Virginia 25701 —
West Virginia University Health Science Center Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00493285, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2012 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00493285 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →